Viking Therapeutics, Inc

(NASDAQ:VKTX)

Latest On Viking Therapeutics, Inc (VKTX):

Date/Time Type Description Signal Details
2023-05-31 11:44 ESTNewsViking Therapeutics a buy at Roth on NASH candidate and pipelineN/A
2023-05-17 23:12 ESTNewsViking Therapeutics: Latest NASH Data Reinforces Drive Towards Finish LineN/A
2023-05-16 20:05 ESTNewsViking stock rises after drug helps reduce liver fat, meets mid-stage study goalN/A
2023-05-16 20:05 ESTNewsHot Stocks: SE and IQ slip after earnings; HZNP down on FTC lawsuit; VOD fall on job cuts; AMD and VKTX gainN/A
2023-05-02 15:34 ESTNewsViking Therapeutics off 5% following CEO stock saleN/A
2023-04-26 23:05 ESTNewsViking Therapeutics GAAP EPS of -$0.25 misses by $0.01N/A
2023-04-26 23:04 ESTNewsViking Therapeutics, Inc. (VKTX) Q1 2023 - Earnings Call TranscriptN/A
2023-04-25 22:45 ESTNewsViking Therapeutics Q1 2023 Earnings PreviewN/A
2023-04-04 22:00 ESTNewsViking Therapeutics: A Promising NASH Diversification PlayN/A
2023-03-30 16:49 ESTNewsViking Therapeutics sheds on pricing $250M stock offeringN/A
2023-03-29 19:41 ESTNewsViking Therapeutics proposes stock offering, size not disclosedN/A
2023-03-29 04:24 ESTNewsWhy did Viking Therapeutics stock soar today? Obesity drug dataN/A
2023-03-28 13:22 ESTNewsViking jumps 39% on early-stage data for obesity candidateN/A
2023-03-28 13:21 ESTNewsHot Stocks: PVH rises on earnings; OXY up on BRK.A stake boost; PARA and CIEN analyst upgrades; VKTX gains; FUTU and LYFT slidesN/A
2023-03-17 00:45 ESTNewsViking Therapeutics: Some Caution WarrantedN/A
2023-02-09 17:02 ESTNewsViking hits multi-year high after Q4 2022 earnings updateN/A
2023-02-09 03:11 ESTNewsViking Therapeutics GAAP EPS of -$0.26 misses by $0.03N/A
2023-02-09 03:11 ESTNewsViking Therapeutics, Inc. (VKTX) Q4 2022 Earnings Call TranscriptN/A
2023-02-08 00:47 ESTNewsViking Therapeutics Q4 2022 Earnings PreviewN/A
2023-01-03 21:58 ESTNewsViking Therapeutics: Booking Profits Following NASH Sympathy MoveN/A
2023-01-03 08:01 ESTNewsViking Therapeutics sues Ascletis Pharma for stealing trade secretsN/A
2022-12-15 00:25 ESTNewsViking Therapeutics: Potential To Embolden Itself In NASH SpaceN/A
2022-10-27 00:15 ESTNewsViking Therapeutics GAAP EPS of -$0.21 beats by $0.02N/A
2022-10-27 00:14 ESTNewsViking Therapeutics, Inc. (VKTX) Q3 2022 Earnings Call TranscriptN/A
2022-08-30 11:34 ESTNewsViking Therapeutics: Playing Second Fiddle To MadrigalN/A
2022-07-28 01:19 ESTNewsViking Therapeutics GAAP EPS of -$0.23 misses by $0.02N/A
2022-07-28 01:19 ESTNewsViking Therapeutics, Inc. (VKTX) CEO Brian Lian on Q2 2022 Results - Earnings Call TranscriptN/A
2022-07-26 22:20 ESTNewsViking Therapeutics Q2 2022 Earnings PreviewN/A
2022-07-19 23:41 ESTNewsFDA lifts clinical hold on Viking's phase 1b trial of its genetic disorder X-ALD treatmentN/A
2022-06-07 03:37 ESTNewsClover Health, Aurinia Pharma among the top 10 health care additions to Russell 3000 Index, Asensus Surgical, Clovis Oncology among top deletionsN/A
2022-04-28 04:50 ESTNewsViking Therapeutics GAAP EPS of -$0.21 misses by $0.02N/A
2022-04-28 04:50 ESTNewsViking Therapeutics' (VKTX) CEO Brian Lian on Q1 2022 Results - Earnings CallN/A
2022-04-26 22:04 ESTNewsViking Therapeutics Q1 2022 Earnings PreviewN/A
2022-04-20 20:04 ESTNewsRevisiting Viking TherapeuticsN/A
2022-02-10 17:26 ESTNewsViking Therapeutics, Inc. (VKTX) CEO Brian Lian on Q4 2021 Results - Earnings CallN/A
2022-02-10 17:25 ESTNewsViking Therapeutics rises 8% following Q4 resultsN/A
2022-02-09 20:23 ESTNewsViking Therapeutics GAAP EPS of -$0.16 beats by $0.03N/A
2022-02-09 02:23 ESTNewsViking Therapeutics Q4 2021 Earnings PreviewN/A
2022-01-24 11:52 ESTNewsFDA puts clinical hold on Viking Therapeutics' Phase 1b trial of VK0214 in X-ALDN/A
2021-11-04 18:23 ESTNewsViking Therapeutics, Inc. (VKTX) CEO Brian Lian on Q3 2021 Results - Earnings Call TranscriptN/A
2021-11-03 21:02 ESTNewsViking Therapeutics EPS beats by $0.04N/A
2021-11-03 01:23 ESTNewsViking Therapeutics Q3 2021 Earnings PreviewN/A
2021-09-22 09:53 ESTNewsViking Therapeutics (VKTX) Investor Presentation - SlideshowN/A
2021-09-22 09:35 ESTNewsViking Therapeutics (VKTX) Investor Prensentation - SlideshowN/A
2021-08-27 17:52 ESTNewsViking Therapeutics: Remaining Bullish And Sticking To My PlanN/A
2021-07-30 03:27 ESTNews89bio and Viking Therapeutics become BTIG’s top picks in NASH spaceN/A
2021-07-29 06:42 ESTNewsViking Therapeutics shares fall after wider Q2 net lossN/A
2021-07-29 06:42 ESTNewsViking Therapeutics, Inc. (VKTX) CEO Brian Lian on Q2 2021 Results - Earnings Call TranscriptN/A
2021-07-22 07:17 ESTNewsCanopy upgraded on economy reopening, Xeris PT cut on acquisition news, and more in analyst actionN/A
2021-07-22 06:59 ESTNewsViking Therapeutics gain 4% premarket as director buys over $113K worthN/A

About Viking Therapeutics, Inc (VKTX):

Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. Its lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trials to treat patients with biopsy-confirmed non-alcoholic steatohepatitis, as well as NAFLD. The company also develops VK5211, an orally available non-steroidal selective androgen receptor modulator that is in Phase II clinical trials for the treatment of patients recovering from non-elective hip fracture surgery; VK0612, an orally available Phase IIb-ready drug candidate for type 2 diabetes; and VK0214, an orally available tissue and receptor-subtype selective agonist of the TRß for X-linked adrenoleukodystrophy. Viking Therapeutics, Inc. was incorporated in 2012 and is headquartered in San Diego, California.

VKTX Quotes by TradingView

See Advanced Chart

General

  • Name Viking Therapeutics, Inc
  • Symbol VKTX
  • Type Common Stock
  • Exchange NASDAQ
  • Currency USD
  • Country USA
  • SectorHealthcare
  • IndustryBiotechnology
  • Full Time Employees 18
  • Fiscal Year EndDecember
  • IPO Date2015-04-29
  • Gic SectorHealth Care
  • Gic GroupPharmaceuticals, Biotechnology & Life Sciences
  • Gic IndustryBiotechnology
  • Gic SubIndustryBiotechnology
  • Web URLhttp://www.vikingtherapeutics.com
View More

Valuation

  • Price/Book (Most Recent Quarter) 2.04
View More

Financials

  • Most Recent Quarter 2020-12-31
  • Current Year EPS Estimate -$0.79
  • Next Year EPS Estimate -$1.03
  • Next Quarter EPS Estimate -$0.17
  • Return on Assets -10%
  • Return on Equity -15%
  • Earnings Per Share -$0.35
  • Revenue Per Share $0
  • Quarterly Earnings Growth 0%
View More

Highlights

  • Market Capitalization 484.09 million
  • PEG Ratio -0.03
  • Analyst Target Price $19.71
  • Book Value Per Share $3.34
View More

Share Statistics

  • Shares Outstanding 74.13 million
  • Shares Float 57.78 million
  • % Held by Insiders 1051%
  • % Held by Institutions 56.71%
  • Shares Short 8.42 million
  • Shares Short Prior Month 8.28 million
  • Short Ratio 4.35
  • Short % of Float 15%
  • Short % of Shares Outstanding 11%
View More

Technicals

  • Beta 1.74
  • 52 Week High $10.09
  • 52 Week Low $3.85
  • 50 Day Moving Average 7.49
  • 200 Day Moving Average 6.51
View More

Dividends

  • Dividend Date N/A
  • ExDividend Date N/A
  • Dividend Yield 0%
View More

Viking Therapeutics, Inc (VKTX) Dividend Calendar:

Ex-Dividend Date Payment Date Record Date Declared Date Amount

Viking Therapeutics, Inc (VKTX) Earnings History:

Companies typically report earnings on both a quarterly and annual basis. Earnings reported that deviate from analysts' expectations can have a large impact on a stock's price.


Quarter Date Report Date Actual Revenue Reported EPS EPS Estimate Deviation from Estimate
2020-12-312021-02-17$N/A-$0.15-$0.151.77%
2020-09-302020-10-28$N/A-$0.13-$0.1513.33%
2020-06-302020-07-29$N/A-$0.13-$0.149.91%
2020-03-312020-04-30$N/A-$0.13-$0.12-6.73%
2019-12-312020-02-26$N/A-$0.10-$0.1322.06%
2019-09-302019-11-05$N/A-$0.08-$0.1336.41%
2019-06-302019-08-01$N/A-$0.11-$0.09-24.58%
2019-03-312019-05-02$N/A-$0.07-$0.0918.22%
2018-12-312019-03-13$N/A-$0.07-$0.1031.37%
2018-09-302018-11-07$N/A-$0.11-$0.126.38%
2018-06-302018-08-09$N/A-$0.13-$0.11-16.8%
2018-03-312018-05-09$N/A-$0.08-$0.1234.43%
2017-12-312018-03-07$N/A-$0.14-$0.1821.35%
2017-09-302017-11-08$N/A-$0.22-$0.20-11.85%
2017-06-302017-08-09$N/A-$0.21-$0.19-12%
2017-03-312017-05-10$N/A-$0.23-$0.17-33.33%
2016-12-312017-03-21$N/A-$0.18-$0.2114.29%
2016-09-302016-11-10$N/A-$0.20-$0.229.91%
2016-06-302016-08-10$N/A-$0.22-$0.22-1.15%
2016-03-312016-05-10$N/A-$0.40-$0.4511.11%
2015-12-312016-03-08$N/A-$0.56-$0.46-21.74%
2015-09-302015-11-05$N/A-$0.53-$0.32-65.63%
2015-06-302015-08-13$N/A-$1.07-$0.13-723.08%
2015-03-312015-06-11$N/A-$1.40$0.28-600%

Viking Therapeutics, Inc (VKTX) Company Financial Statements:

Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.

Income Statement:
Date
Research Development
Income Before Tax
Selling General Administrative
Gross Profit
Ebit
Operating Income
Income Tax Expense
Total Revenue
Cost of Revenue
Total Other Income Expense Net
Net Income From Continuing Operations
Net Income Applicable to Common Shares
Cash Flow:
Date
Investments
Change to Liabilities
Total Cash Flow from Investing Activities
Net Borrowings
Total Cash Flow from Financial Activities
Change to Operating Activities
Change in Cash
Total Cash from Operating Activities
Depreciation
Other Cash Flow from Investing Activities
Change to Inventory
Change to Account Receivables
Other Cash Flow from Financing Activities
Change to Net Income
Capital Expenditures
Balance Sheet:
Date
Total Liabailities
Total Stockholder Equity
Other Current Liabilities
Total Assets
Common Stock
Other Current Assets
Retained Earnings
Other Liabilities
Other Assets
Cash
Total Current Liabilities
Other Stockholder Equity
Property, Plant & Equipment
Total Current Assets
Long Term Investments
Net Tangible Assets
Short Term Investments
Long Term Debt
Inventory
Accounts Payable

Viking Therapeutics, Inc (VKTX) Chart:

Viking Therapeutics, Inc (VKTX) News:

Below you will find a list of latest news for Viking Therapeutics, Inc (VKTX) from major news sources. You can filter the results to only show news from a specific source.

No recent news available

Viking Therapeutics, Inc (VKTX) Options:

A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.

Expiration Date Strike Last Price Type Volume Open Interest Implied Volatility In The Money Change Change Percent
2025-01-17363CALL0 15245.34TRUE00
2025-01-17561.5CALL0 103185.64TRUE00
2025-01-17756.9CALL0 340130.18TRUE00
2025-01-171048CALL0 4065312.04TRUE00
2025-01-171251CALL0 69164.81TRUE00
2025-01-171553.03CALL0 710147.94TRUE00
2025-01-171754.4CALL0 291137.12TRUE00
2025-01-172043.8CALL0 797118.28TRUE00
2025-01-172249.06CALL0 621110.49TRUE00
2025-01-172543CALL0 1075112.06TRUE00
2025-01-172736.28CALL0 30107.98TRUE00
2025-01-173032.5CALL2 185963.83TRUE-1.5-0.04
2025-01-173230.7CALL0 1797.65TRUE00
2025-01-173528.52CALL1 99297.25TRUE28.520
2025-01-173732.2CALL0 7394.71TRUE00
2025-01-174024.59CALL2 70393.82TRUE-1.75-0.07
2025-01-174228.2CALL0 3793.43TRUE00
2025-01-174521.9CALL0 5692.47TRUE00
2025-01-174720.1CALL2 31190.59TRUE20.10
2025-01-175017.8CALL5 72292.08TRUE-2.2-0.11
2025-01-175515.5CALL11 98589.79TRUE-0.5-0.03
2025-01-1757.50CALL0 090.74TRUE00
2025-01-176013.3CALL40 106590.94TRUE-0.3-0.02
2025-01-1762.512.15CALL12 9190.12FALSE12.150
2025-01-176511.2CALL26 175490.25FALSE-0.3-0.03
2025-01-1767.511.1CALL0 890.2FALSE00
2025-01-17709.6CALL121 469191.13FALSE-0.7-0.07
2025-01-1772.58.6CALL1 4689.35FALSE8.60
2025-01-17758CALL69 205990.09FALSE-0.25-0.03
2025-01-1777.58CALL0 65290.43FALSE00
2025-01-17806.54CALL43 433390FALSE-0.56-0.08
2025-01-17855.75CALL10 250790.36FALSE-0.15-0.03
2025-01-17904.8CALL40 71989.82FALSE-0.05-0.01
2025-01-17954.15CALL0 52389.3FALSE00
2025-01-171003.4CALL139 346289.5FALSE-0.1-0.03
2025-01-171052.69CALL15 13687.56FALSE2.690
2025-01-171102.5CALL0 55197.88FALSE00
2025-01-171151.95CALL0 63895.17FALSE00
2025-01-171201.85CALL18 99590.79FALSE0.050.03
2025-01-171252CALL2 66196.5FALSE20
2025-01-171301.3CALL1 139590.02FALSE1.30
2025-01-171350.6CALL1 89179.54FALSE-0.5-0.45
2025-01-171400.8CALL26 29886.99FALSE0.80
2025-01-171450.8CALL5 151789.77FALSE-0.15-0.16
2025-01-1730.03PUT0 70FALSE00
2025-01-1750.05PUT0 1320FALSE00
2025-01-1770.05PUT0 2650FALSE00
2025-01-17100.05PUT0 17240FALSE00
2025-01-17120.05PUT0 1890FALSE00
2025-01-17150.6PUT0 290FALSE00
2025-01-17170.2PUT0 1780FALSE00
2025-01-17200.48PUT0 1300FALSE00
2025-01-17221.2PUT0 890FALSE00
2025-01-17250.3PUT0 21699.49FALSE00
2025-01-17270.45PUT0 140FALSE00
2025-01-17300.8PUT2 25596.73FALSE0.80
2025-01-17321PUT2 11094.8FALSE0.150.18
2025-01-17351.45PUT3 30893.83FALSE0.180.14
2025-01-17371.9PUT0 139094.69FALSE00
2025-01-17402.41PUT0 72991.84FALSE00
2025-01-17422.77PUT0 19192.93FALSE00
2025-01-17453.9PUT10 49391.87FALSE3.90
2025-01-17474.3PUT0 49291.33FALSE00
2025-01-17505.8PUT5 188992.11FALSE0.330.06
2025-01-17557.7PUT4 59589.02FALSE7.70
2025-01-1757.50PUT0 090.61FALSE00
2025-01-176010.45PUT2 69790.22FALSE0.350.03
2025-01-1762.511.5PUT0 15989.59TRUE00
2025-01-176513.4PUT5 126190.27TRUE0.80.06
2025-01-1767.514.2PUT0 9289.63TRUE00
2025-01-177016.72PUT1 56390.86TRUE0.720.05
2025-01-1772.517.8PUT0 1490.18TRUE00
2025-01-177519.3PUT0 52989.94TRUE00
2025-01-1777.520.3PUT0 17590.4TRUE00
2025-01-178022.4PUT0 25189.3TRUE00
2025-01-178528PUT0 18389.02TRUE00
2025-01-179025.9PUT0 11588.12TRUE00
2025-01-179530.8PUT0 2287.55TRUE00
2025-01-1710033PUT0 5891.68TRUE00
2025-01-1710541.3PUT0 892.7TRUE00
2025-01-1711045.1PUT0 22387.96TRUE00
2025-01-1711550.1PUT0 690.65TRUE00
2025-01-1712049.1PUT0 189.9TRUE00
2025-01-1712558.05PUT0 2098.45TRUE00
2025-01-171300PUT0 0103.8TRUE00
2025-01-1713555.4PUT0 0105.4TRUE00
2025-01-1714080.7PUT0 087.76TRUE00
2025-01-1714583.9PUT0 088.2TRUE00
2025-02-212547.5CALL0 12108.14TRUE00
2025-02-213034.8CALL0 38101.38TRUE00
2025-02-2132.50CALL0 0107.41TRUE00
2025-02-213533.6CALL0 2994.37TRUE00
2025-02-2137.50CALL0 097.79TRUE00
2025-02-214027.55CALL0 139101.58TRUE00
2025-02-2142.50CALL0 098.7TRUE00
2025-02-214523.74CALL0 4994.51TRUE00
2025-02-2147.50CALL0 098.88TRUE00
2025-02-215019.69CALL0 34090.13TRUE00
2025-02-215518CALL0 14088.24TRUE00
2025-02-2157.50CALL0 089.75TRUE00
2025-02-216015.5CALL0 13189.26TRUE00
2025-02-2162.514.05CALL17 190.33FALSE14.050
2025-02-216513CALL3 20289.6FALSE00
2025-02-2167.50CALL0 188.46FALSE00
2025-02-217011CALL0 48187.61FALSE00
2025-02-2172.50CALL0 1391.57FALSE00
2025-02-21759.7CALL0 22787.1FALSE00
2025-02-2177.50CALL0 087.48FALSE00
2025-02-21807.2CALL5 67689.52FALSE-1.37-0.16
2025-02-21856.8CALL0 33585.52FALSE00
2025-02-21905.82CALL0 32283.66FALSE00
2025-02-21955.7CALL0 8184.32FALSE00
2025-02-211003.8CALL1 55980.62FALSE-0.7-0.16
2025-02-211050CALL0 085.66FALSE00
2025-02-21250.65PUT0 789FALSE00
2025-02-21301.2PUT0 3399.12FALSE00
2025-02-2132.50PUT0 00FALSE00
2025-02-21352.25PUT0 22399.41FALSE00
2025-02-2137.50PUT0 0105.3FALSE00
2025-02-21403.2PUT0 20691.16FALSE00
2025-02-2142.53.9PUT0 1093.77FALSE00
2025-02-21455.2PUT0 16092.93FALSE00
2025-02-2147.50PUT0 091.64FALSE00
2025-02-21507.1PUT0 18994.29FALSE00
2025-02-21558.9PUT0 18690.67FALSE00
2025-02-2157.50PUT0 092.69FALSE00
2025-02-216011.6PUT77 21487.15FALSE11.60
2025-02-2162.50PUT0 093.21TRUE00
2025-02-216514.17PUT0 2990.29TRUE00
2025-02-2167.50PUT0 087.7TRUE00
2025-02-217017.7PUT0 8087.35TRUE00
2025-02-2172.50PUT0 084.68TRUE00
2025-02-217517.92PUT0 885.86TRUE00
2025-02-2177.50PUT0 084.08TRUE00
2025-02-218024.3PUT0 485.59TRUE00
2025-02-218524.79PUT0 1084.73TRUE00
2025-02-219028PUT0 182.25TRUE00
2025-02-219530.4PUT0 384.15TRUE00
2025-02-2110033.01PUT0 284.52TRUE00
2025-02-211050PUT0 083.5TRUE00
2025-05-1632.50CALL0 0100.43TRUE00
2025-05-16350CALL0 893.35TRUE00
2025-05-1637.50CALL0 093.29TRUE00
2025-05-16400CALL0 093.38TRUE00
2025-05-1642.50CALL0 094.4TRUE00
2025-05-164525.5CALL2 690.71TRUE25.50
2025-05-1647.532.8CALL0 288.33TRUE00
2025-05-165022.8CALL1 689.64TRUE22.80
2025-05-165520.45CALL138 589.22TRUE20.450
2025-05-1657.527CALL0 590.08TRUE00
2025-05-166017.4CALL1 1787.74TRUE17.40
2025-05-1662.50CALL0 086.86FALSE00
2025-05-166516CALL0 1586.26FALSE00
2025-05-1667.514.65CALL10 087.01FALSE14.650
2025-05-167013.8CALL21 4483.04FALSE13.80
2025-05-1672.514.1CALL0 2483.83FALSE00
2025-05-167512.9CALL0 7588.76FALSE00
2025-05-1677.50CALL0 681.89FALSE00
2025-05-16800CALL0 081.26FALSE00
2025-05-16850CALL0 084.57FALSE00
2025-05-169012.9CALL0 583.62FALSE00
2025-05-169512.8CALL0 484.96FALSE00
2025-05-161006.7CALL1 1880.34FALSE6.70
2025-05-161050CALL0 182.88FALSE00
2025-05-1632.52.87PUT0 194.09FALSE00
2025-05-16350PUT0 880.55FALSE00
2025-05-1637.54.36PUT0 183.5FALSE00
2025-05-16405.2PUT0 580.66FALSE00
2025-05-1642.56.16PUT0 384.81FALSE00
2025-05-16456.45PUT0 190.22FALSE00
2025-05-1647.57.9PUT0 087.91FALSE00
2025-05-16509.3PUT0 3490.24FALSE00
2025-05-165511PUT0 8790.68FALSE00
2025-05-1657.50PUT0 089.17FALSE00
2025-05-166014.5PUT0 1787.42FALSE00
2025-05-1662.515.34PUT0 2883.79TRUE00
2025-05-166516.57PUT0 588.6TRUE00
2025-05-1667.518.56PUT0 3887.68TRUE00
2025-05-167020.25PUT0 4082.61TRUE00
2025-05-1672.519.42PUT0 1081.28TRUE00
2025-05-167520.85PUT0 1082.81TRUE00
2025-05-1677.50PUT0 081.27TRUE00
2025-05-16800PUT0 086.22TRUE00
2025-05-16850PUT0 086.03TRUE00
2025-05-16900PUT0 085.66TRUE00
2025-05-16950PUT0 085.16TRUE00
2025-05-161000PUT0 085.73TRUE00
2025-05-161050PUT0 086.11TRUE00
2026-01-16352CALL0 5162.14TRUE00
2026-01-16548.5CALL0 6155.64TRUE00
2026-01-16857CALL0 13117.14TRUE00
2026-01-161057.1CALL0 46117.45TRUE00
2026-01-16120CALL0 00TRUE00
2026-01-161349.8CALL0 43108.87TRUE00
2026-01-161554CALL0 170106.95TRUE00
2026-01-161749.1CALL0 135104.56TRUE00
2026-01-162044.9CALL10 53489.05TRUE-1.83-0.04
2026-01-162246CALL0 3394.93TRUE00
2026-01-162542.9CALL0 8697.63TRUE00
2026-01-162732.1CALL0 6493.68TRUE00
2026-01-163038.3CALL0 41594.09TRUE00
2026-01-163231CALL0 1389.11TRUE00
2026-01-163536.4CALL0 13588.76TRUE00
2026-01-163751.7CALL0 289.48TRUE00
2026-01-164033.27CALL1 21288.65TRUE-0.13-0
2026-01-164240.1CALL0 1790.3TRUE00
2026-01-164530.6CALL1 3786.35TRUE30.60
2026-01-164731.8CALL0 2988.6TRUE00
2026-01-165028.2CALL135 63484.74TRUE-0.2-0.01
2026-01-165526.08CALL1 23483.75TRUE26.080
2026-01-1657.525.4CALL0 681.87TRUE00
2026-01-166023.1CALL2 57878.61TRUE-1.6-0.06
2026-01-1662.524.3CALL0 184.03FALSE00
2026-01-166521.9CALL0 25884.52FALSE00
2026-01-1667.50CALL0 081.92FALSE00
2026-01-167020CALL2 21978.73FALSE200
2026-01-1672.50CALL0 084FALSE00
2026-01-167519CALL0 91682.86FALSE00
2026-01-1677.50CALL0 081.1FALSE00
2026-01-168017.6CALL0 23382.94FALSE00
2026-01-168519.15CALL0 11478.86FALSE00
2026-01-169015.1CALL16 28178.29FALSE-0.25-0.02
2026-01-169514.21CALL0 13578.67FALSE00
2026-01-1610011.95CALL39 182176.1FALSE-2.25-0.16
2026-01-1610511.6CALL0 10577.55FALSE00
2026-01-1611012.25CALL0 7075.19FALSE00
2026-01-1611510.7CALL0 26276.22FALSE00
2026-01-1612015.4CALL0 15976.71FALSE00
2026-01-1612511.95CALL0 3674.78FALSE00
2026-01-161308.74CALL0 45975.87FALSE00
2026-01-161357CALL0 53175.48FALSE00
2026-01-161408.9CALL0 84375.13FALSE00
2026-01-161456CALL21 77370.9FALSE00
2026-01-1630PUT0 00FALSE00
2026-01-1650.3PUT0 120FALSE00
2026-01-1680.5PUT0 720FALSE00
2026-01-16100.6PUT0 168101.51FALSE00
2026-01-16120PUT0 00FALSE00
2026-01-16131.01PUT0 860FALSE00
2026-01-16152PUT0 190FALSE00
2026-01-16172.44PUT0 210FALSE00
2026-01-16202PUT0 770FALSE00
2026-01-16222.72PUT1 4592.18FALSE2.720
2026-01-16253.58PUT0 14591.54FALSE00
2026-01-16273.08PUT0 289.82FALSE00
2026-01-16305.2PUT0 26193.29FALSE00
2026-01-16325.9PUT0 688.68FALSE00
2026-01-16356.9PUT0 792.17FALSE00
2026-01-16378.8PUT0 587.62FALSE00
2026-01-16409.07PUT0 25686.96FALSE00
2026-01-16429.9PUT0 3786.2FALSE00
2026-01-164510.9PUT0 5385.72FALSE00
2026-01-164712.35PUT0 8085.13FALSE00
2026-01-165013.8PUT0 20084.61FALSE00
2026-01-165516.5PUT0 13287.16FALSE00
2026-01-1657.50PUT0 082.93FALSE00
2026-01-166019.8PUT1 100183.93FALSE19.80
2026-01-1662.50PUT0 082.29TRUE00
2026-01-166522PUT0 20279.79TRUE00
2026-01-1667.523.8PUT0 1281.68TRUE00
2026-01-167026PUT1 14482.23TRUE260
2026-01-1672.50PUT0 078.88TRUE00
2026-01-167528.7PUT0 35079.94TRUE00
2026-01-1677.50PUT0 079.03TRUE00
2026-01-168040.05PUT0 11278.58TRUE00
2026-01-168528.9PUT0 28379.36TRUE00
2026-01-169048.2PUT0 1079.22TRUE00
2026-01-169530.75PUT0 377.48TRUE00
2026-01-1610051PUT0 377.43TRUE00
2026-01-1610561.18PUT0 277.07TRUE00
2026-01-1611055PUT0 174.68TRUE00
2026-01-161150PUT0 074.68TRUE00
2026-01-1612063.59PUT0 1375.25TRUE00
2026-01-161250PUT0 073.94TRUE00
2026-01-1613073PUT0 172.66TRUE00
2026-01-1613569.5PUT0 472.45TRUE00
2026-01-161400PUT0 073.92TRUE00
2026-01-1614581PUT0 574.54TRUE00
2027-01-1532.50CALL0 088.24TRUE00
2027-01-15350CALL0 085.71TRUE00
2027-01-1537.50CALL0 084.47TRUE00
2027-01-154038CALL0 1384.3TRUE00
2027-01-1542.50CALL0 082.86TRUE00
2027-01-15450CALL0 082.42TRUE00
2027-01-1547.50CALL0 081.86TRUE00
2027-01-15500CALL0 081.2TRUE00
2027-01-15550CALL0 081.44TRUE00
2027-01-1557.50CALL0 080.33TRUE00
2027-01-156030.8CALL0 3478.17TRUE00
2027-01-1562.535.45CALL0 279.33FALSE00
2027-01-156529.25CALL0 579.22FALSE00
2027-01-1567.531.55CALL0 1477.93FALSE00
2027-01-157028.85CALL0 478.01FALSE00
2027-01-1572.525.5CALL1 175.57FALSE25.50
2027-01-157524.9CALL2 875.55FALSE-2.1-0.08
2027-01-1577.50CALL0 077.24FALSE00
2027-01-158025CALL0 2475.9FALSE00
2027-01-158526.67CALL0 276.17FALSE00
2027-01-159021.25CALL5 5274.12FALSE21.250
2027-01-15950CALL0 174.03FALSE00
2027-01-1510020.7CALL0 1975.7FALSE00
2027-01-1510516.6CALL1 068.55FALSE16.60
2027-01-1532.57.7PUT0 179.12FALSE00
2027-01-15350PUT0 483.12FALSE00
2027-01-1537.50PUT0 181.62FALSE00
2027-01-154011.31PUT0 280.06FALSE00
2027-01-1542.50PUT0 080.79FALSE00
2027-01-15450PUT0 081.06FALSE00
2027-01-1547.516PUT0 179.19FALSE00
2027-01-155017PUT0 1180.13FALSE00
2027-01-155519.82PUT0 378.95FALSE00
2027-01-1557.50PUT0 079.26FALSE00
2027-01-156022.26PUT0 15274.32FALSE00
2027-01-1562.50PUT0 077.25TRUE00
2027-01-15650PUT0 076.8TRUE00
2027-01-1567.50PUT0 076.44TRUE00
2027-01-157027.75PUT0 376.46TRUE00
2027-01-1572.50PUT0 076.25TRUE00
2027-01-15750PUT0 075.53TRUE00
2027-01-1577.50PUT0 074.9TRUE00
2027-01-15800PUT0 074.65TRUE00
2027-01-15850PUT0 074.98TRUE00
2027-01-159043PUT0 1073.26TRUE00
2027-01-15950PUT0 072.48TRUE00
2027-01-151000PUT0 072.44TRUE00
2027-01-151050PUT0 072.08TRUE00

Latest VKTX Trades:

Date Shares Price
Jun 13, 2022 7:58 PM EST100$2.125
Jun 13, 2022 7:58 PM EST100$2.125
Jun 13, 2022 7:58 PM EST38$2.125
Jun 13, 2022 7:59 PM EST90$2.13
Jun 13, 2022 7:59 PM EST100$2.13

Viking Therapeutics, Inc (VKTX) SEC Filings:

An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.

Date Form Type Form Name Link
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120039521/0001209191-20-039521-index.htm
2018-07-17UPLOADSEC-generated letterhttps://www.sec.gov/Archives/edgar/data/1607678/000000000018021941/0000000000-18-021941-index.htm
2019-02-13SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000009375119000115/0000093751-19-000115-index.htm
2019-04-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000009375119000378/0000093751-19-000378-index.htm
2020-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000009375120000478/0000093751-20-000478-index.htm
2019-02-08SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000021545719006859/0000215457-19-006859-index.htm
2018-10-10SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000031506618002427/0000315066-18-002427-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000031506619001442/0000315066-19-001442-index.htm
2020-02-07SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000031506620001268/0000315066-20-001268-index.htm
2020-02-06SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000083423720006932/0000834237-20-006932-index.htm
2018-09-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000089924318025453/0000899243-18-025453-index.htm
2020-08-274Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000089924320023546/0000899243-20-023546-index.htm
2020-08-284/AStatement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000089924320023644/0000899243-20-023644-index.htm
2018-06-07S-3MEFRegistration adding securities to prior Form S-3 registration [Rule 462(b)]https://www.sec.gov/Archives/edgar/data/1607678/000095012318006165/0000950123-18-006165-index.htm
2018-07-11S-3Registration statement under Securities Act of 1933https://www.sec.gov/Archives/edgar/data/1607678/000095012318006751/0000950123-18-006751-index.htm
2019-02-14SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000117266119000513/0001172661-19-000513-index.htm
2019-10-10SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000117266119002034/0001172661-19-002034-index.htm
2020-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000117266120000911/0001172661-20-000911-index.htm
2019-02-13SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000117891319000440/0001178913-19-000440-index.htm
2018-02-12SC 13GStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000119312518040234/0001193125-18-040234-index.htm
2018-11-13SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1607678/000119312518325600/0001193125-18-325600-index.htm
2019-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000119312519040832/0001193125-19-040832-index.htm
2020-08-28SC 13D/AGeneral statement of acquisition of beneficial ownershiphttps://www.sec.gov/Archives/edgar/data/1607678/000119312520234860/0001193125-20-234860-index.htm
2018-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919118028717/0001209191-18-028717-index.htm
2018-05-084Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919118028718/0001209191-18-028718-index.htm
2018-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919118034482/0001209191-18-034482-index.htm
2018-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919118034485/0001209191-18-034485-index.htm
2018-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919118034490/0001209191-18-034490-index.htm
2018-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919118034494/0001209191-18-034494-index.htm
2018-05-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919118034496/0001209191-18-034496-index.htm
2018-07-033Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919118041226/0001209191-18-041226-index.htm
2018-07-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919118041236/0001209191-18-041236-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119001558/0001209191-19-001558-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119001561/0001209191-19-001561-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119001563/0001209191-19-001563-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119001564/0001209191-19-001564-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119001566/0001209191-19-001566-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119001568/0001209191-19-001568-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119001571/0001209191-19-001571-index.htm
2019-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119001575/0001209191-19-001575-index.htm
2019-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119004858/0001209191-19-004858-index.htm
2019-01-224Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119004861/0001209191-19-004861-index.htm
2019-07-023Initial statement of beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119040257/0001209191-19-040257-index.htm
2019-07-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119040272/0001209191-19-040272-index.htm
2019-08-024Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119044336/0001209191-19-044336-index.htm
2019-10-314Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919119054654/0001209191-19-054654-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120001418/0001209191-20-001418-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120001419/0001209191-20-001419-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120001420/0001209191-20-001420-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120001421/0001209191-20-001421-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120001422/0001209191-20-001422-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120001425/0001209191-20-001425-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120001426/0001209191-20-001426-index.htm
2020-01-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120001428/0001209191-20-001428-index.htm
2020-01-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120004311/0001209191-20-004311-index.htm
2020-01-214Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120004314/0001209191-20-004314-index.htm
2020-04-034Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120023378/0001209191-20-023378-index.htm
2020-06-304Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120039521/0001209191-20-039521-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120050732/0001209191-20-050732-index.htm
2020-09-164Statement of changes in beneficial ownership of securitieshttps://www.sec.gov/Archives/edgar/data/1607678/000120919120050734/0001209191-20-050734-index.htm
2018-02-01424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1607678/000156459018001200/0001564590-18-001200-index.htm
2018-02-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459018001242/0001564590-18-001242-index.htm
2018-02-05424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1607678/000156459018001325/0001564590-18-001325-index.htm
2018-02-068-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459018001404/0001564590-18-001404-index.htm
2018-02-14SC 13G/AStatement of acquisition of beneficial ownership by individualshttps://www.sec.gov/Archives/edgar/data/1607678/000156459018002076/0001564590-18-002076-index.htm
2018-03-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459018004723/0001564590-18-004723-index.htm
2018-03-0710-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1607678/000156459018004757/0001564590-18-004757-index.htm
2018-03-07S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1607678/000156459018004759/0001564590-18-004759-index.htm
2018-04-06DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1607678/000156459018007765/0001564590-18-007765-index.htm
2018-04-06DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1607678/000156459018007777/0001564590-18-007777-index.htm
2018-05-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459018012440/0001564590-18-012440-index.htm
2018-05-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1607678/000156459018012501/0001564590-18-012501-index.htm
2018-05-318-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459018014719/0001564590-18-014719-index.htm
2018-06-06424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1607678/000156459018015152/0001564590-18-015152-index.htm
2018-06-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459018015228/0001564590-18-015228-index.htm
2018-06-07424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1607678/000156459018015256/0001564590-18-015256-index.htm
2018-06-128-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459018015450/0001564590-18-015450-index.htm
2018-07-17CORRESPCorrespondencehttps://www.sec.gov/Archives/edgar/data/1607678/000156459018016919/0001564590-18-016919-index.htm
2018-08-098-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459018021053/0001564590-18-021053-index.htm
2018-08-0910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1607678/000156459018021125/0001564590-18-021125-index.htm
2018-09-188-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459018023246/0001564590-18-023246-index.htm
2018-09-19424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1607678/000156459018023312/0001564590-18-023312-index.htm
2018-09-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459018023407/0001564590-18-023407-index.htm
2018-09-21424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1607678/000156459018023464/0001564590-18-023464-index.htm
2018-11-078-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459018028008/0001564590-18-028008-index.htm
2018-11-0710-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1607678/000156459018028101/0001564590-18-028101-index.htm
2019-03-138-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459019007569/0001564590-19-007569-index.htm
2019-03-1310-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1607678/000156459019007584/0001564590-19-007584-index.htm
2019-03-13S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1607678/000156459019007589/0001564590-19-007589-index.htm
2019-04-05DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1607678/000156459019010928/0001564590-19-010928-index.htm
2019-04-05DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1607678/000156459019010933/0001564590-19-010933-index.htm
2019-05-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459019015327/0001564590-19-015327-index.htm
2019-05-0210-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1607678/000156459019015390/0001564590-19-015390-index.htm
2019-05-238-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459019020346/0001564590-19-020346-index.htm
2019-07-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459019024412/0001564590-19-024412-index.htm
2019-08-018-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459019027983/0001564590-19-027983-index.htm
2019-08-0110-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1607678/000156459019028043/0001564590-19-028043-index.htm
2019-08-02424B5Prospectus [Rule 424(b)(5)]https://www.sec.gov/Archives/edgar/data/1607678/000156459019028058/0001564590-19-028058-index.htm
2019-08-028-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459019028063/0001564590-19-028063-index.htm
2019-11-058-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459019040059/0001564590-19-040059-index.htm
2019-11-0510-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1607678/000156459019040424/0001564590-19-040424-index.htm
2020-02-2610-KAnnual report [Section 13 and 15(d), not S-K Item 405]https://www.sec.gov/Archives/edgar/data/1607678/000156459020006766/0001564590-20-006766-index.htm
2020-02-26S-8Securities to be offered to employees in employee benefit planshttps://www.sec.gov/Archives/edgar/data/1607678/000156459020006838/0001564590-20-006838-index.htm
2020-03-178-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459020011413/0001564590-20-011413-index.htm
2020-04-06DEF 14AOther definitive proxy statementshttps://www.sec.gov/Archives/edgar/data/1607678/000156459020015522/0001564590-20-015522-index.htm
2020-04-06DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1607678/000156459020015533/0001564590-20-015533-index.htm
2020-04-308-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459020020180/0001564590-20-020180-index.htm
2020-04-3010-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1607678/000156459020020233/0001564590-20-020233-index.htm
2020-05-20DEFA14AAdditional definitive proxy soliciting materials and Rule 14(a)(12) materialhttps://www.sec.gov/Archives/edgar/data/1607678/000156459020026393/0001564590-20-026393-index.htm
2020-05-218-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459020026582/0001564590-20-026582-index.htm
2020-07-298-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459020034308/0001564590-20-034308-index.htm
2020-07-2910-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1607678/000156459020034329/0001564590-20-034329-index.htm
2020-10-288-KCurrent reporthttps://www.sec.gov/Archives/edgar/data/1607678/000156459020048337/0001564590-20-048337-index.htm
2020-10-2810-QQuarterly report [Sections 13 or 15(d)]https://www.sec.gov/Archives/edgar/data/1607678/000156459020048398/0001564590-20-048398-index.htm
2018-07-19EFFECTNotice of Effectivenesshttps://www.sec.gov/Archives/edgar/data/1607678/999999999518001837/9999999995-18-001837-index.htm
2020-02-19CT ORDERConfidential treatment orderhttps://www.sec.gov/Archives/edgar/data/1607678/999999999720000814/9999999997-20-000814-index.htm

Viking Therapeutics, Inc (VKTX) Insider Transactions:

Here you will find a list of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Viking Therapeutics, Inc (VKTX). Company insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.
Insider Ownership: 1051%
Institutional Ownership: 5671%

Transaction Date Insider Name Insider Title Type Shares Number Shares Price Total Transaction Shares Held After Transaction Link
2018-07-01Hiroko MasamuneChief Development OfficerBuy15,000.00111,197.00https://www.sec.gov/Archives/edgar/data/1607678/000120919118041236/0001209191-18-041236-index.htm
2019-01-03Hiroko MasamuneChief Development OfficerBuy22,667.00141,063.00https://www.sec.gov/Archives/edgar/data/1607678/000120919119001571/0001209191-19-001571-index.htm
2019-01-03Brian LianPresident & CEOBuy80,897.001,564,485.00https://www.sec.gov/Archives/edgar/data/1607678/000120919119001568/0001209191-19-001568-index.htm
2020-01-03Brian LianPresident & CEOBuy153,333.001,714,289.00https://www.sec.gov/Archives/edgar/data/1607678/000120919120001426/0001209191-20-001426-index.htm
2020-09-15Brian LianPresident & CEOBuy55,500.001,761,555.00https://www.sec.gov/Archives/edgar/data/1607678/000120919120050732/0001209191-20-050732-index.htm
2020-06-30MATTHEW W FOEHRDirectorSell13,000.007.3595,550.0026,250.00https://www.sec.gov/Archives/edgar/data/1607678/000120919120039521/0001209191-20-039521-index.htm
2018-05-29Charles A Jr RowlandDirectorBuy30,000.005.16154,800.0030,000.00https://www.sec.gov/Archives/edgar/data/1607678/000120919118034490/0001209191-18-034490-index.htm
2018-05-29LAWSON MACARTNEYDirectorBuy47,965.005.22250,329.3447,965.00https://www.sec.gov/Archives/edgar/data/1607678/000120919118034482/0001209191-18-034482-index.htm
2020-08-26LIGAND PHARMACEUTICALS INC10% Share HolderSell94,488.008.11766,108.705,819,383.00https://www.sec.gov/Archives/edgar/data/1607678/000089924320023546/0000899243-20-023546-index.htm
2020-08-25LIGAND PHARMACEUTICALS INC10% Share HolderSell70,000.008.02561,575.005,968,083.00https://www.sec.gov/Archives/edgar/data/1607678/000089924320023546/0000899243-20-023546-index.htm
2018-09-25LIGAND PHARMACEUTICALS INC10% Share HolderSell262,881.0019.155,034,250.016,038,083.00https://www.sec.gov/Archives/edgar/data/1607678/000089924318025453/0000899243-18-025453-index.htm
2018-05-29Stephen W WebsterDirectorBuy8,000.005.2141,712.008,000.00https://www.sec.gov/Archives/edgar/data/1607678/000120919118034485/0001209191-18-034485-index.htm
2018-05-31MICHAEL MORNEAUVP, Finance and AdministrationSell21,551.009.25199,346.7594,035.00https://www.sec.gov/Archives/edgar/data/1607678/000120919118034494/0001209191-18-034494-index.htm
2018-05-31J MATTHEW SINGLETONDirectorBuy9,500.009.8293,260.559,500.00https://www.sec.gov/Archives/edgar/data/1607678/000120919118034496/0001209191-18-034496-index.htm
2020-09-15MICHAEL MORNEAUVP, Finance and AdministrationBuy4,500.0099,430.00https://www.sec.gov/Archives/edgar/data/1607678/000120919120050734/0001209191-20-050734-index.htm